Natco Pharma Ltd

NSE: NATCOPHARM BSE: 524816

₹815.35

(0.40%)

Thu, 17 Sept 2026, 00:03 pm

MTF 5xInvest in Natco Pharma Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)14669.1

PE Ratio12.76

Dividend0.55

Health Technology

Pharmaceuticals: Major

24.5K

Natco Pharma News

Natco Pharma Gets Tentative FDA Nod for Olaparib Tablets

Natco Pharma receives tentative FDA approval for Olaparib Tablets, with Alembic Pharmaceuticals set to distribute in the U.S., where the drug sees ~$1.4 billion in sales by March 2026.

18 Jul 2026

companies

Natco Pharma gets GST order

Natco Pharma received a GST order demanding Rs 60 lakh. The demand includes tax, interest, and penalty for RCM discrepancies.

14 Jul 2026

companies

Natco Pharma to Raise Adcock Ingram Stake to 49%

Natco Pharma plans to increase its stake in Adcock Ingram from 35.75% to 49% by acquiring 19.6 million shares for ₹1,069 crore, alongside a ₹1,400 crore investment in its South Africa subsidiary.

08 Jul 2026

companies

Natco Pharma appoints two senior VPs

Natco Pharma designated Gnanadeva Chalapathy Gudipati as Senior Vice President and Madhava Rao Karicherla as Vice President effective July 6, 2026.

06 Jul 2026

companies

Natco Pharma VP Operations superannuates

Nadella Malleswara Rao superannuated as VP - Operations on June 30, 2026. The change was disclosed under SEBI regulations.

30 Jun 2026

companies

Showing 1–5 of 82

Rows per page:

Market Current News

KALPATARU PROJECTS INTERNATION

Kalpataru Projects gets IPO prospectus nod for Nasdaq Stockholm

Kalpataru Projects International has received approval for its IPO prospectus to list on Nasdaq Stockholm, marking a significant cross-border capital market development.

16 Sept 2026

ipo

KALPATARU PROJECTS INTERNATION

Kalpataru subsidiary Linjemontage sets IPO price at SEK 46

Kalpataru Projects International Ltd's Swedish EPC subsidiary Linjemontage has priced its IPO at SEK 46 per share, valuing the firm at SEK 2.35 billion. The listing on Nasdaq Stockholm is scheduled for September 25, 2026.

16 Sept 2026

ipo

S.K. Offset IPO DRHP: ₹66.67 Cr Revenue

S.K. Offset Limited files DRHP for SME IPO opening Sep 23, 2026. Revenue surged to ₹66.67 crore in FY26 with PAT at ₹7.48 crore. Funds for working capital.

16 Sept 2026

ipo

Vivekanand Cotspin IPO: Key DRHP Details

Vivekanand Cotspin files DRHP for SME IPO opening Sep 21, 2026. The Gujarat-based yarn manufacturer reports FY26 revenue of ₹408.01 crore. Proceeds fund machinery and working capital.

16 Sept 2026

ipo

FX Multitech IPO DRHP: ₹31.09 Cr Use of Proceeds

FX Multitech Limited files DRHP for SME IPO. Consolidated revenue hits ₹126.14 Cr in FY26. Funds to repay debt, fund working capital, and invest in subsidiary Everestt Chillers.

16 Sept 2026

ipo

Showing 1–5 of 94265

Rows per page: